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Abstract
Introduction: In critical illness, four measures of glycaemic control are associated with ICU mortality: mean glucose
concentration, glucose variability, the incidence of hypoglycaemia (≤ 2.2 mmol/l) or low glucose (2.3 to 4.7 mmol/l).
Underlying diabetes mellitus (DM) might affect these associations. Our objective was to study whether the association
between these measures of glycaemic control and ICU mortality differs between patients without and with DM and to
explore the cutoff value for detrimental low glucose in both cohorts.
Methods: This retrospective database cohort study included patients admitted between January 2004 and June
2011 to a 24-bed medical/surgical ICU in a teaching hospital. We analysed glucose and outcome data from 10,320
patients: 8,682 without DM and 1,638 with DM. The cohorts were subdivided into quintiles of mean glucose and
quartiles of glucose variability. Multivariable regression models were used to examine the independent association
between the four measures of glycaemic control and ICU mortality, and for defining the cutoff value for
detrimental low glucose.
Results: Regarding mean glucose, a U-shaped relation was observed in the non-DM cohort with an increased ICU
mortality in the lowest and highest glucose quintiles (odds ratio = 1.4 and 1.8, P < 0.001). No clear pattern was
found in the DM cohort. Glucose variability was related to ICU mortality only in the non-DM cohort, with highest
ICU mortality in the upper variability quartile (odds ratio = 1.7, P < 0.001). Hypoglycaemia was associated with ICU
mortality in both cohorts (odds ratio non-DM = 2.5, P < 0.001; odds ratio DM = 4.2, P = 0.001), while low-glucose
concentrations up to 4.9 mmol/l were associated with an increased risk of ICU mortality in the non-DM cohort and
up to 3.5 mmol/l in the DM cohort.
Conclusion: Mean glucose and high glucose variability are related to ICU mortality in the non-DM cohort but not
in the DM cohort. Hypoglycaemia (≤ 2.2 mmol/l) was associated with ICU mortality in both. The cutoff value for
detrimental low glucose is higher in the non-DM cohort (4.9 mmol/l) than in the DM cohort (3.5 mmol/l). While
hypoglycaemia (≤ 2.2 mmol/l) should be avoided in both groups, DM patients seem to tolerate a wider glucose
range than non-DM patients.
Introduction
Hyperglycaemia, hypoglycaemia and increased glucose
variability in critically ill patients are independently asso-
ciated with ICU mortality [1-6]. In the last decade many
clinical triallists have attempted to improve mortality rates
through intensive insulin therapy. Unfortunately, these
trials have produced conflicting data, with some of the stu-
dies showing lower and others higher mortality with strict
glucose control, the latter possibly due to an increased
incidence of hypoglycaemia [7-12]. There is consensus
about the importance to avoid hypoglycaemia and many
ICUs have therefore increased their lower glucose limit
[13]. However, there is no consensus about the optimal
target glucose range. In a previous database cohort study,
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we found an optimal mean glucose range of 6.7 to
8.4 mmol/l in a medical cohort and 7.0 to 9.4 mmol/l in a
surgical cohort [14]. We additionally found that glucose
concentrations that were low but above hypoglycaemic
levels (between 2.3 and 4.7 mmol/l) were associated with
increased ICU mortality [3]. Thus, in addition to the mean
glucose concentration, glucose variability and hypoglycae-
mia, a fourth measure of glycaemic control - low glucose
(2.3 to 4.7 mmol/l) - is associated with ICU mortality in
the critically ill.
Underlying diabetes mellitus (DM) might affect the
abovementioned associations. In a recent review we exam-
ined the current literature on glycaemic control and mor-
tality in diabetic ICU patients and we found that, despite
patients with DM having an increased risk of developing
complications when admitted to the ICU, their risk of
mortality is not increased [15]. In addition, ICU patients
with DM have lower mortality in the higher mean glucose
range compared with those without DM, although varying
cutoff values were used [16-19]. Some studies found the
opposite, with higher mortality rates for DM patients in
the low-normal mean glucose range. However, these find-
ings were unadjusted results only [18,20] and this relation
was not significant after adjustment for severity of disease
[16]. Furthermore, high glucose variability in ICU patients
with DM seems to be less harmful than in patients without
DM [21,22] although data are limited. Lastly, hypoglycae-
mia is associated with mortality in patients with and with-
out DM [3,4,23], while the risk of hypoglycaemia is higher
in patients with DM [4,24]. Altogether, some of the above-
mentioned findings are inconsistent and none of the
reviewed studies evaluated all four measures of glycaemic
control concomitantly.
The objective of this study was to determine whether the
association between measures of glycaemic control - mean
glucose, glucose variability (measured as the mean abso-
lute glucose (MAG) change), the occurrence of hypogly-
caemia (≤ 2.2 mmol/l) or low glucose (2.3 to 4.7 mmol/l) -
and ICU mortality differs between patients without and
with underlying DM in a large cohort of critically ill
patients admitted to a general ICU of a teaching hospital
in the Netherlands. We also explored the cutoff value for
detrimental low glucose in both populations.
Materials and methods
Design and setting
The current study was conducted as a single-centre retro-
spective database cohort study in a 24-bed mixed surgical/
medical ICU in a teaching hospital (Onze Lieve Vrouwe
Gasthuis, Amsterdam, the Netherlands). All data were col-
lected prospectively. All beds were equipped with a clinical
information system (MetaVision; iMDsoft, Tel Aviv, Israel)
from which clinical and laboratory data were extracted.
The nurse-to-patient ratio was on average 1:2, depending
on the severity of disease. According to national guidelines
this research is exempt from ethical approval because it is
a retrospective study. The requirement for informed con-
sent was waived because all data were anonymous and col-
lected retrospectively.
Glucose regulation protocol
A glucose regulation protocol, with a target blood glu-
cose concentration of 4.0 to 7.0 mmol/l, was implemen-
ted in 2001 after the publication of the study by van den
Berghe and colleagues [7]. The glucose regulation sliding
scale algorithm was connected to the clinical information
system and fully computerised with an integrated deci-
sion support module controlling the algorithm [25]. The
glucose regulation protocol has been reported previously
[2,3,14]. In April 2009, following the publication of the
Normoglycaemia in Intensive Care Evaluation - Survival
Using Glucose Algorithm Regulation investigators in
2009 [11], a new target blood glucose concentration of
5.0 to 9.0 mmol/l was instituted. To date, this new target
blood glucose range is maintained in routine intensive
care management.
Cohort and data collection
Relevant data were extracted from the clinical information
system concerning patients admitted to the ICU between
January 2004 and June 2011. Readmissions, patients with a
withholding care policy, and patients with < 3 glucose
values during ICU admission were excluded. The assign-
ment of each patient’s diabetic status on ICU admission
was based on the use of oral glucose-lowering drugs and/
or insulin therapy. Demographic variables, admission diag-
nosis, glucose values, the occurrence of hypoglycaemia
and ICU and hospital mortality rates were assessed. Sever-
ity of disease was assessed using the Acute Physiology and
Chronic Health Evaluation (APACHE) II score on admis-
sion [26]. For each subsequent day of ICU admission, the
Sequential Organ Failure Assessment score was assessed
as a measurement of severity of disease [27]. The maximal
Sequential Organ Failure Assessment score was deter-
mined for the patient’s entire stay in the ICU [28].
Glucose measurements
Glucose was measured from blood samples obtained
from an arterial catheter using the Accu-chek (Roche/
Hitachi, Basel, Switzerland). Results were automatically
stored in the clinical information system. For each
patient, mean glucose during admission was calculated
from all glucose values measured during ICU admission.
As markers for glucose variability, the MAG change [2]
and the standard deviation were calculated per patient.
Hypoglycaemia was defined as one or more glucose
values ≤ 2.2 mmol/l, which is in accordance with pre-
vious trials [7,11]. Although our blood glucose target
Sechterberger et al. Critical Care 2013, 17:R52
http://ccforum.com/content/17/2/R52
Page 2 of 10
range in the initial years was between 4.0 and 7.0 mmol/l,
we later found an association between the presence of a
glucose value ≤ 4.7 mmol/l and ICU mortality [3]. Low
glucose was therefore defined as the presence of at least
one glucose value between 2.3 and 4.7 mmol/l.
Statistical analyses
Continuous data are presented as mean (standard devia-
tion) or median (interquartile range), as appropriate, and
compared using Student’s t test or the Mann-Whitney
rank-sum test, respectively. Categorical data are presented
as percentages and compared using the chi-square test. In
accordance with our previous studies, mean glucose and
glucose variability (MAG change) were categorised into
equally sized quintiles [14] and quartiles [2] and were
plotted against ICU mortality for the DM and non-DM
cohorts separately.
The independent association between mean glucose and
ICU mortality was examined using multivariable logistic
regression analysis calculating odds ratios (ORs) with 95%
confidence intervals (CIs). The quintile with the lowest
mortality incidence was used as a reference. Based on clin-
ical relevance and prognostic scoring, we adjusted for
demographics (age, sex), severity of disease (using the
APACHE II score), hypoglycaemia (≤ 2.2 mmol/l) and car-
diothoracic surgery as the admission category. Cardiothor-
acic surgery was included as a covariate for several
reasons: a generally lower mortality in this group com-
pared with other surgical patients, a relatively low
APACHE II score, a relatively short length of ICU stay
and several different demographic and physiological char-
acteristics of this group from the general ICU population,
which could be reflected in differences in mean glucose
concentration and glucose variability [29]. In an alternative
model, adjustment was made for the occurrence of glucose
values ≤ 4.7 mmol/l, which is also independently asso-
ciated with mortality [3,30].
A second multivariable regression model was used to
assess the independent association between glucose varia-
bility (MAG change) and ICU mortality, the quartile with
lowest mortality incidence used as a reference. In this
model the same potential confounders were used includ-
ing the variable mean glucose. Furthermore, to assess the
association between hypoglycaemia (≤ 2.2 mmol/l) and
low glucose (2.3 to 4.7 mmol/l) and ICU mortality, unad-
justed and adjusted ORs with 95% CIs were calculated, the
latter using a third multivariable regression model adjusted
for age, sex, severity of disease, cardiothoracic surgery and
sepsis as admission diagnoses.
In both cohorts, we also assessed the cutoff value for
detrimental low glucose, by performing the latter analysis
for different blood glucose cutoff values. Additionally,
when we adjusted the logistic regression models for the
change in target glucose range in the studied period, no
change in our results was observed (data not shown). All
statistical analyses were performed in SPSS 18.0 (SPSS Inc,
Chicago, IL, USA).
Results
From 11,901 ICU admissions, 10,320 patients were
selected for analyses after excluding 842 readmissions,
105 patients with a withholding care policy, and 714
patients with < 3 glucose measurements. The remaining
cohort consisted of 8,682 (84.2%) patients who did not
have DM at the time of ICU admission (non-DM
cohort) and 1,638 (15.8%) patients who had DM at the
time of ICU admission (DM cohort). The percentage of
medical and surgical ICU admissions in the entire
cohort was 26% and 74%. The non-DM:DM ratio within
these groups was 9:1 in patients with a medical ICU
admission diagnosis and 4:1 in patients with a surgical
ICU admission diagnosis. Table 1 illustrates patient
characteristics of the entire study population as well as
the differences between the non-DM cohort and the
DM cohort.
Association between mean glucose concentration
and ICU mortality
Figure 1 demonstrates the quintiles of mean glucose
ranges per cohort (non-DM cohort: < 6.8, 6.8 to 7.3,
7.3 to 7.9, 7.9 to 8.9, > 8.9 mmol/l; DM cohort: < 6.9,
6.9 to 7.4, 7.4 to 8.0, 8.0 to 8.9, > 8.9 mmol/l) and cor-
responding ICU mortality rates. This resulted in a
U-shaped relationship between mean glucose and ICU
mortality in the non-DM cohort, with high ICU mor-
tality in the lowest and highest glucose quintile (11.8%
and 7.7%). Multivariable logistic regression analysis in
the non-DM cohort showed that mean glucose values
in the lowest and highest quintiles were associated
with a significantly higher OR for ICU mortality com-
pared with the quintile with the lowest ICU mortality
(Figure 2). This was supported by a significant non-
linear relationship between mean glucose and ICU
mortality (P for trend < 0.001). When we adjusted the
logistic regression model for the occurrence of glucose
values ≤ 4.7 mmol/l, the OR for ICU mortality in the
lowest quintile no longer reached significance in the
non-DM cohort (OR = 1.3, 95% CI = 0.9 to 1.8, P =
0.17). The increased ICU mortality in the non-DM
cohort in the lower part of the U-curve therefore
seems to be due to the relation between glucose values
≤ 4.7 mmol/l and ICU mortality. In contrast, no clear
pattern was found in the DM cohort in unadjusted
(Figure 1B) or multivariate analysis (data not shown).
Association between glucose variability and ICU mortality
The ranges of MAG change per quartile (non-DM
cohort: < 0.37, 0.37 to 0.56, 0.56 to 0.82, > 0.82 mmol/l/
Sechterberger et al. Critical Care 2013, 17:R52
http://ccforum.com/content/17/2/R52
Page 3 of 10
hour; DM cohort: < 0.56, 0.56 to 0.76, 0.76 to 1.03,
> 1.03 mmol/l/hour) and corresponding ICU mortality
per cohort are shown in Figure 3. This resulted in a lin-
ear relationship in the non-DM cohort, with the highest
mortality rate seen in the upper MAG quartile (13.4%).
Multivariable logistic regression analysis for the non-
DM cohort is displayed in Figure 4; the OR for ICU
mortality was highest in the upper MAG change quartile
(OR = 1.69, P = 0.001). This was supported by a signifi-
cant relationship between MAG quartiles and ICU mor-
tality (P for trend = 0.004). In contrast, in the DM
cohort no clear pattern was found in unadjusted (Figure
3B) or multivariate analysis (data not shown).
Association between hypoglycaemia and low glucose
and ICU mortality
The percentage of patients who experienced at least one
episode of hypoglycaemia (≤ 2.2 mmol/l) was similar in
both cohorts (Table 1). Low glucose (2.3 to 4.7 mmol/l)
occurred more frequently in the DM cohort. The
increase in glucose target range as introduced in 2009
decreased the percentage of patients who experienced






P valueª Total cohort
(n = 10,320)
Age (years) 65 ± 13 68 ± 10 < 0.001 65 ± 13
Male sex 5804 (67) 1,032 (63) 0.003 6,836 (66)
Body mass index (kg/m2) 27 ± 14 29 ± 5 < 0.001 27 ± 13
APACHE II score on admission 16 (13 to 21) 16 (13 to 20) 0.006 16 (13 to 21)
Maximum SOFA score during admissionb 6 (5 to 8) 6 (5 to 7) 0.09 6 (5 to 8)
ICU stay (hours) 26 (20 to 66) 23 (19 to 49) < 0.001 25 (20 to 64)
Died in the ICU 622 (7) 73 (5) < 0.001 695 (7)
Died in the hospital 994 (11) 144 (9) 0.001 1,138 (11)
Medical admissions 2,444 (28) 266 (16) < 0.001 2,710 (26)
Surgical admissions 6,238 (72) 1,372 (84) < 0.001 7,610 (74)
Cardiothoracic surgery patients 4,877 (56) 1,214 (74) < 0.001 6,091 (59)
APACHE II admission category
Cardiovascular 5,776 (67) 1,338 (82) < 0.001 7114 (69)
Sepsis 628 (7) 93 (6) 0.02 721 (7)
After cardiac arrest 534 (6) 37 (2) < 0.001 571 (6)
Gastrointestinal 474 (5) 43 (3) < 0.001 517 (5)
Haematological 18 (0) 1 (0) 0.205 19 (0)
Renal 60 (1) 9 (1) 0.519 69 (1)
Metabolic 81(1) 14 (1) 0.761 95 (1)
Neurological 266 (3) 12 (1) < 0.001 278 (3)
Respiratory 845 (10) 91 (6) < 0.001 936 (9)
Glucose values per patient 12 (7 to 27) 14 (11 to 28) < 0.001 13 (8 to 28)
Overall glucose (mmol/l) 8.0 ± 1.7 8.0 ± 1.6 0.577 8.0 ± 1.6
Morning glucose (mmol/l) 7.6 ± 2.0 7.0 ± 2.0 < 0.001 7.5 ± 2.0
Mean absolute glucose change (mmol/l/hour) 0.6 (0.4 to 0.8) 0.8 (0.6 to 1.0) < 0.001 0.7 (0.4 to 0.9)
Standard deviation (mmol/l) 1.7 (1.3 to 2.3) 2.1 (1.6 to 2.7) < 0.001 1.8 (1.4 to 2.4)
Incidence hypoglycaemia ≤ 2.2 mmol/lc 310 (4) 57 (4) 0.856 367 (4)
Incidence glucose value 2.3 to 4.7 mmol/lc 3,715 (43) 901 (55) < 0.001 4,616 (45)
Use of insulin 6,686 (77) 1,610 (98) < 0.001 8,296 (80)
Insulin dose (IU/hour) 2.2 (1.7 to 3.1) 2.8 (2.0 to 4.0) < 0.001 2.3 (1.8 to 3.3)
Use of vasopressor drugs 8,020 (92) 1,551 (95) 0.001 9,571 (93)
Use of corticosteroids 8,561 (99) 1,636 (100) < 0.001 10,197 (99)
Mechanical ventilationd 8,039 (93) 1,539 (94) 0.050 9,578 (93)
Continuous veno-venous haemofiltration 690 (8) 116 (7) 0.231 806 (8)
Data presented as mean ± standard deviation, n (%) or median (interquartile range). APACHE, Acute Physiology and Chronic Health Evaluation; SOFA, Sequential
Organ Failure Assessment. aBased on Student’s t test or the Mann-Whitney rank-sum test (continuous data), or the chi-square test (categorical data), comparing
patients with and without diabetes. bMaximum score during admission, calculated from the total individual scores calculated each ICU day. cPatients who
experienced at least one hypoglycaemia or glucose value between 2.3 and 4.7 mmol/l. dIn the first 24 hours of ICU admission.
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both hypoglycaemia (before 3.3%; after 0.3%) and low
glucose (before 36.3%; after 8.4%).
ICU mortality rates for hypoglycaemia were 29.7% and
21.1% in the non-DM and DM cohorts, respectively.
Unadjusted ORs of hypoglycaemia (≤ 2.2 mmol/l) for
ICU mortality in the occurrence of hypoglycaemia were
6.2 (95% CI = 4.8 to 8.1, P < 0.001) in the non-DM
cohort and 6.6 (95% CI = 3.3 to 13.1, P < 0.001) in the
DM cohort. In logistic regression analysis, adjusted for
potential confounders (see above), the OR of hypogly-
caemia for ICU mortality was still significant in both
cohorts (non-DM cohort: OR = 2.5, 95% CI = 1.8 to 3.4,
P < 0.001; DM cohort: OR = 4.2, 95% CI = 1.8 to 10.1,
P = 0.001).
ICU mortality rates for low glucose (2.3 to 4.7 mmol/l)
were 13.1% and 5.2% in the non-DM and DM cohorts,
respectively. The OR of low glucose for ICU mortality was
significant in the non-DM cohort (unadjusted OR = 5.3,
95% CI = 4.4 to 6.4, P < 0.001; adjusted OR = 1.5, 95%
CI = 1.2 to 1.9, P < 0.001). When exploring the cutoff
value for detrimental low glucose in the non-DM cohort,
we found that lowest blood glucose concentrations up to
4.9 mmol/l were associated with an increased risk for ICU
mortality (adjusted OR = 1.3, 95% CI = 1.1 to 1.7, P =
0.01). In contrast, when exploring the cutoff value for det-
rimental low glucose in the DM cohort, we found that
lowest blood glucose concentrations up to 3.5 mmol/l
were associated with an increased risk of ICU mortality
(adjusted OR = 2.1, 95% CI = 1.2 to 3.7, P = 0.01). With
glucose values between 3.5 and 4.7 mmol/l, no significant
effect on the OR for ICU mortality was found. Poisson
regression analysis, which we used in a previous study to
adjust for daily Sequential Organ Failure Assessment score
over time [3], amounted to similar results (data not
shown).
Discussion
In this retrospective database cohort study evaluating the
association of four measures of glycaemic control and ICU
mortality concomitantly, we found striking differences
between the non-DM cohort and the DM cohort. In the
non-DM cohort, ICU mortality was significantly related to
all four measures of glycaemic control: mean glucose, glu-
cose variability, the occurrence of hypoglycaemia (≤ 2.2
mmol/l) and low glucose concentrations up to 4.9 mmol/l.
In contrast, in the DM cohort, only the occurrence of
hypoglycaemia (≤ 2.2 mmol/l) and low-glucose concentra-
tions up to 3.5 mmol/l were significantly associated with
ICU mortality, while mean glucose and glucose variability
were not. The presence of DM thus seems to affect the
association between glucose control and ICU mortality.
Our findings support the results of previous studies that
have focused on understanding the association between
the presence of DM at ICU admission, glycaemia, and ICU
mortality [7,8,16-19,31,32]. In all these studies, a stronger
association between hyperglycaemia and ICU mortality
was found in patients without DM, in comparison with
patients with DM.
Hypoglycaemia has been found to be a risk factor of
mortality in patients without and with DM in the literature
[3,4,7,8,30,33,34]. Of note, different cutoff values were
used to define hypoglycaemia, ranging from ≤ 2.2 mmol/l
[4,35] up to ≤ 4.7 mmol/l [3,33]. We also found a signifi-
cant independent association between hypoglycaemia
Mean Glucose (mmol/L)
















































Figure 1 ICU mortality per quintile of mean glucose in the nondiabetes mellitus and diabetes mellitus cohorts. ICU mortality (%) per
quintile of mean glucose in (A) the nondiabetes mellitus cohort and (B) the diabetes mellitus cohort. Numbers above bars indicate the number
of deaths per mean glucose quintile.
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(≤ 2.2 mmol/l) and ICU mortality, in both the non-DM
and DM cohorts. However, the association between low
glucose (2.3 and 4.7 mmol/l) and ICU mortality was only
significant in the non-DM cohort, not in the DM cohort.
When exploring the cutoff value for detrimental low glu-
cose in the present cohort, we found that lowest blood
glucose concentrations up to 4.9 mmol/l were associated
with an increased risk of ICU mortality in the non-DM
cohort, and 3.5 mmol/l in the DM cohort. The cutoff
value in the non-DM cohort is in line with our previous
study, in which we found that lowest glucose values up to
4.7 mmol/l were associated with significant increased ICU
mortality [3]. Furthermore, this cutoff value is supported
by the finding that the higher mortality in the lower half
of the U-shaped curve (< 6.8 mmol/l) in the non-DM
cohort is mainly determined by the occurrence of glucose
values ≤ 4.7 mmol/l and less by the glucose range between
4.7 and 6.8 mmol/l. The cutoff value for detrimental low
glucose we found in our DM cohort (≤ 3.5 mmol/l) is also
in line with the literature [23,30]. Both studies found that
glucose concentrations ≤ 3.9 mmol/l were significantly
associated with mortality in a subgroup of DM patients.
Altogether, we can conclude that the cutoff value for detri-
mental low glucose is lower in the DM population than in
the non-DM population.
The association between glucose variability and ICU
mortality in patients without and with DM was studied
previously [22]. In this observational study of 4,084
glucose (mmol/L) OR Mortality (95% CI) p- value
< 6.8 1.40 (1.0 - 2.0) 0.04
6.8-7.3 1.02 (0.7 - 1.4) 0.90
7.3-7.9 0.90 (0.6 - 1.3) 0.55
7.9-8.9 Reference n.a.
> 8.9 1.83 (1.3 - 2.6) <0.001
p for trend: < 0.001
Mean Glucose (mmol/L)















Figure 2 Odds ratio for ICU mortality per quintile of mean glucose in the nondiabetes mellitus cohort. All odds ratios (ORs) were
calculated per quintile of mean glucose and adjusted for age, sex, Acute Physiology and Chronic Health Evaluation II admission score,
cardiothoracic surgery as admission diagnosis and the occurrence of hypoglycaemia (≤ 2.2 mmol/l). *P < 0.05. CI, confidence interval.
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patients (including 942 DM patients), a strong association
of glucose variability - expressed as the coefficient of varia-
tion (standard deviation/mean glucose level) - with mor-
tality was found in patients without DM, while, in
concordance with our study, no association was found in
patients with DM [22]. Of note, this measure of glucose
variability does not take order and time into account.
Several explanations can be considered for the different
associations between glycaemic control and ICU mortal-
ity in patients without and with pre-existing DM. We
previously suggested that adaptation to hyperglycaemia
might be a key mechanism [15]. Acute hyperglycaemia
and inflammation induce oxidative stress, which causes
endothelial damage [36]. In patients without DM, cellular
adaptation mechanisms will be activated for the first time
in the acute care setting, whereas patients with DM
could already have adapted to these insults during their
years with DM and therefore better tolerate episodes of
hyperglycaemia in an acute care setting. In addition, cel-
lular adaptation to recurrent hypoglycaemia is also a
well-established phenomenon [37-39]. Although specula-
tive, adaptation to low glucose will already be present in
patients with DM and might explain why patients with
DM can withstand relatively low glucose values better.
Our results should be viewed in light of the study’s
strengths and limitations. Strengths of our study include
the large number of ICU patients and that glucose values
were captured automatically, which prevents transcrip-
tion errors. Furthermore, this is the first study examining
all four markers of glycaemic control in a non-DM
cohort and a DM cohort simultaneously. Also, we used a
time-based metric for glucose variability and we explored
multiple cutoff values for hypoglycaemia. Potential lim-
itations of the study are that it is a single-centre study
and retrospective in design, and thus is potentially sub-
ject to systematic error and bias. However, all data were
prospectively collected and independently measured.
Moreover, the findings are robust and internally
consistent.
As in all studies in this field, our definition for a patient’s
diabetic status may be nonrepresentative. Unfortunately,
glycosylated haemoglobin testing was not performed
before ICU admission and we were unable to make a dis-
tinction between type 1 and type 2 DM patients. In addi-
tion, we were not able to distinguish between diabetes
patients with good and poor chronic control, who may
become hyperglycaemic due to acute illness. Whether this
might affect the optimal glucose target for the DM cohort
remains unknown.
Another limitation was that we were not able to distin-
guish between spontaneous (illness-related) and treat-
ment-induced hypoglycaemia or variability. However,
other studies could make this distinction. Finfer and col-
leagues reported that patients who had encountered severe
or moderate hypoglycaemia while not being treated with
insulin were at an increased mortality risk [23]. But they
also demonstrated that, although to a lesser extent, insu-
lin-induced hypoglycaemia was associated with an
increased risk for ICU death. In contrast, Kosiborod and
colleagues only reported a high risk for mortality in
patients hospitalised with acute myocardial infarction who
developed hypoglycaemia spontaneously. Iatrogenic hypo-
glycaemia after insulin therapy was not associated with
higher mortality risk [40].
MAG change (mmol/L/hr)












































17  16  17
23
A B
Figure 3 ICU mortality per mean absolute glucose change quartile in non-diabetes mellitus and diabetes mellitus cohorts. ICU
mortality (%) per mean absolute glucose change (MAG) quartile in (A) the nondiabetes mellitus cohort and (B) the diabetes mellitus cohort.
Numbers above bars indicate number of deaths per mean absolute glucose change quartile.
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Furthermore, in our cohort, most patients were admitted
for cardiothoracic surgery; we corrected for this potential
confounder in our regression analyses and still found
significantly increased ICU mortality in the lowest and
highest mean glucose quintiles and in the highest glucose
variability quartile in the non-DM cohort. Moreover, the
high amount of cardiothoracic surgery patients in the stu-
died cohort may also have contributed to the high admin-
istration level of corticosteroids. In our hospital, as in
many European hospitals (but not in most North Ameri-
can cardiac surgical centres), corticosteroid administration
during cardiac surgery is part of routine care. All patients
who were in shock or had sepsis or systemic inflammatory
response syndrome also received corticosteroids. This
could possibly limit the external validity of this single-cen-
tre study.
In our analyses of glucose variability, we did not correct
for the frequency of glucose measurements during ICU
admission. However, we did correct for severity of disease,
which in itself is clearly correlated with the frequency of
glucose measurements and ICU mortality. Furthermore,
the concern that the frequency of blood glucose measure-
ments may influence the relation between the MAG and
ICU mortality has been previously discussed [41]. MAG is
independent of the number of measurements, as long as
blood glucose keeps changing at a constant rate. The
MAG only increases when there is actually more glucose
variability. The possibility to capture variability, if there is
MAG change (mmol/L/hr)













   *
MAG change  (mmol/L/hr) OR Mortality (95% CI) p- value
< 0.37             Reference n.a.
0.37-0.56       1.20 (0.9-1.7) 0.29
0.56-0.82         1.28 (0.9-1.8) 0.13
> 0.82            1.69 (1.2-2.3) 0.001
p for trend = 0.004
Figure 4 Odds ratio for ICU mortality over mean absolute glucose quartiles in the nondiabetes mellitus cohort. All odds ratios (ORs)
were calculated per quartile of mean absolute glucose (MAG) change and adjusted for age, sex, Acute Physiology and Chronic Health Evaluation
II admission score, mean glucose, cardiothoracic surgery as admission diagnosis and the occurrence of hypoglycaemia (≤ 2.2 mmol/l). *P < 0.05.
CI, confidence interval.
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any, increases when the number of glucose measurements
is increased. However, this can be said for all measures of
glucose variability and this is not unique for the MAG
change.
A limitation of our correction for severity of disease is
the use of the APACHE II score. Although the valida-
tion of the use of APACHE II score to predict mortality
in cardiac surgery patients is lacking, this adjustment is
the best available method [29]. Finally, because of the
observational nature of the study, no proof of causation
can be derived from the abovementioned associations
between glycaemic control and ICU mortality.
Conclusion
This retrospective database cohort study shows that the
presence of DM affects the association between three
out of four measures of glycaemic control and ICU mor-
tality. Mean glucose and high glucose variability were
associated with ICU mortality in the non-DM cohort
but not in the DM cohort, whereas hypoglycaemia (≤
2.2 mmol/l) was associated with ICU mortality in both.
We additionally found a higher cutoff value for detri-
mental low glucose in our non-DM cohort (4.9 mmol/l)
than the DM cohort (3.5 mmol/l). Glucose concentra-
tions ≤ 4.9 mmol/l should therefore be avoided in the
non-DM cohort, while DM patients seem to tolerate a
wider glucose range. Further studies should examine
whether new technologies - that is, continuous glucose
monitoring technology - could be of use for clinicians to
improve glycaemic control.
Key messages
• The presence of DM affects the association
between three out of four measures of glycaemic
control and ICU mortality.
• Mean glucose relates to ICU mortality by a U-shaped
curve in the non-DM population, whereas no clear
association was found in the DM population.
• High glucose variability is only related to ICU
mortality in the non-DM cohort.
• The occurrence of hypoglycaemia (≤ 2.2 mmol/l) is
related to ICU mortality in both populations and
should undoubtedly be avoided.
• The cutoff value for detrimental low glucose in the
non-DM population (4.9 mmol/l) seems to be higher
than in the DM population (3.5 mmol/l).
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